Quoin Pharmaceuticals Statistics
Want to see QNRX full AI Analyst Report?
Quoin Pharmaceuticals (QNRX) Stock Statistics & Valuation Metrics
Total Valuation
Quoin Pharmaceuticals has a market cap or net worth of $16.14M. The enterprise value is -$10.19M.
- Market Cap
- $16.14M
- Enterprise Value
- -$10.19M
Share Statistics
Quoin Pharmaceuticals has 4,804,161 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,804,161
- Owned by Insiders
- 3.80%
- Owned by Institutions
- 48.43%
Financial Efficiency
Quoin Pharmaceuticals’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is -109.75%.
- Return on Equity (ROE)
- -1.20
- Return on Assets (ROA)
- -0.78
- Return on Invested Capital (ROIC)
- -109.75%
- Return on Capital Employed (ROCE)
- -1.10
- Revenue Per Employee
- 0
- Profits Per Employee
- -3.95M
- Employee Count
- 4
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Quoin Pharmaceuticals is -0.36. Quoin Pharmaceuticals’s PEG ratio is -0.00.
- PE Ratio
- -0.36
- PS Ratio
- 0.00
- PB Ratio
- 0.58
- Price to FCF
- -0.35
- Price to Operating Cash Flow
- -0.87
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Quoin Pharmaceuticals had revenue of 0 and earned -15.80M in profits. Earnings per share was -14.80.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -16.29M
- Pretax Income
- -15.80M
- Net Income
- -15.80M
- EBITDA
- -15.70M
- Earnings Per Share (EPS)
- -14.80
Cash Flow
In the last 12 months, operating cash flow was -18.93M and capital expenditures 1, giving a free cash flow of -18.93M billion.
- Operating Cash Flow
- -18.93M
- Free Cash Flow
- -18.93M
- Free Cash Flow per Share
- -3.75
Dividends & Yields
Quoin Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -282.29%
- Earnings Yield
- -116.86%
Stock Price Statistics
- Beta
- -0.19
- 52-Week Price Change
- -82.19%
- 50-Day Moving Average
- 4.78
- 200-Day Moving Average
- 5.68
- Relative Strength Index (RSI)
- 32.65
- Average Volume (3m)
- 539.84K
Important Dates
Quoin Pharmaceuticals upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Quoin Pharmaceuticals as a current ratio of 3.61, with Debt / Equity ratio of 0.00%
- Current Ratio
- 3.61
- Quick Ratio
- 3.61
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 243.12
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Quoin Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Quoin Pharmaceuticals EV to EBITDA ratio is 0.17, with an EV/FCF ratio of 0.18.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.17
- EV to Free Cash Flow
- 0.18
- EV to Operating Cash Flow
- 0.18
Balance Sheet
Quoin Pharmaceuticals has $10.10M in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.10M billion.
- Cash & Marketable Securities
- $10.10M
- Total Debt
- $0.00
- Net Cash
- $10.10M
- Net Cash Per Share
- $2.10
- Tangible Book Value Per Share
- $5.63
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Quoin Pharmaceuticals is $17.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $17.60
- Price Target Upside
- 436.59% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 98.98%
Scores
- Smart Score
- ―
- AI Score
- 46

